Global Antibody Development Services Market Research Report 2024

Report ID: 1896918 | Published Date: Sep 2024 | No. of Page: 115 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antibody Development Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibody Development
        1.2.3 Polyclonal Antibody Development
    1.3 Market by Application
        1.3.1 Global Antibody Development Services Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Medical Industry
        1.3.3 Biological Industry
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Antibody Development Services Market Perspective (2017-2028)
    2.2 Antibody Development Services Growth Trends by Region
        2.2.1 Antibody Development Services Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Antibody Development Services Historic Market Size by Region (2017-2022)
        2.2.3 Antibody Development Services Forecasted Market Size by Region (2023-2028)
    2.3 Antibody Development Services Market Dynamics
        2.3.1 Antibody Development Services Industry Trends
        2.3.2 Antibody Development Services Market Drivers
        2.3.3 Antibody Development Services Market Challenges
        2.3.4 Antibody Development Services Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Antibody Development Services Players by Revenue
        3.1.1 Global Top Antibody Development Services Players by Revenue (2017-2022)
        3.1.2 Global Antibody Development Services Revenue Market Share by Players (2017-2022)
    3.2 Global Antibody Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Antibody Development Services Revenue
    3.4 Global Antibody Development Services Market Concentration Ratio
        3.4.1 Global Antibody Development Services Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antibody Development Services Revenue in 2021
    3.5 Antibody Development Services Key Players Head office and Area Served
    3.6 Key Players Antibody Development Services Product Solution and Service
    3.7 Date of Enter into Antibody Development Services Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Development Services Breakdown Data by Type
    4.1 Global Antibody Development Services Historic Market Size by Type (2017-2022)
    4.2 Global Antibody Development Services Forecasted Market Size by Type (2023-2028)
5 Antibody Development Services Breakdown Data by Application
    5.1 Global Antibody Development Services Historic Market Size by Application (2017-2022)
    5.2 Global Antibody Development Services Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Antibody Development Services Market Size (2017-2028)
    6.2 North America Antibody Development Services Market Size by Country (2017-2022)
    6.3 North America Antibody Development Services Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Antibody Development Services Market Size (2017-2028)
    7.2 Europe Antibody Development Services Market Size by Country (2017-2022)
    7.3 Europe Antibody Development Services Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Antibody Development Services Market Size (2017-2028)
    8.2 Asia-Pacific Antibody Development Services Market Size by Country (2017-2022)
    8.3 Asia-Pacific Antibody Development Services Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Antibody Development Services Market Size (2017-2028)
    9.2 Latin America Antibody Development Services Market Size by Country (2017-2022)
    9.3 Latin America Antibody Development Services Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Antibody Development Services Market Size (2017-2028)
    10.2 Middle East & Africa Antibody Development Services Market Size by Country (2017-2022)
    10.3 Middle East & Africa Antibody Development Services Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Detail
        11.1.2 Thermo Fisher Scientific Business Overview
        11.1.3 Thermo Fisher Scientific Antibody Development Services Introduction
        11.1.4 Thermo Fisher Scientific Revenue in Antibody Development Services Business (2017-2022)
        11.1.5 Thermo Fisher Scientific Recent Development
    11.2 R&D Systems
        11.2.1 R&D Systems Company Detail
        11.2.2 R&D Systems Business Overview
        11.2.3 R&D Systems Antibody Development Services Introduction
        11.2.4 R&D Systems Revenue in Antibody Development Services Business (2017-2022)
        11.2.5 R&D Systems Recent Development
    11.3 Leinco Technologies
        11.3.1 Leinco Technologies Company Detail
        11.3.2 Leinco Technologies Business Overview
        11.3.3 Leinco Technologies Antibody Development Services Introduction
        11.3.4 Leinco Technologies Revenue in Antibody Development Services Business (2017-2022)
        11.3.5 Leinco Technologies Recent Development
    11.4 Rockland Immunochemicals, Inc. (Rockland)
        11.4.1 Rockland Immunochemicals, Inc. (Rockland) Company Detail
        11.4.2 Rockland Immunochemicals, Inc. (Rockland) Business Overview
        11.4.3 Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Introduction
        11.4.4 Rockland Immunochemicals, Inc. (Rockland) Revenue in Antibody Development Services Business (2017-2022)
        11.4.5 Rockland Immunochemicals, Inc. (Rockland) Recent Development
    11.5 Bio-Rad
        11.5.1 Bio-Rad Company Detail
        11.5.2 Bio-Rad Business Overview
        11.5.3 Bio-Rad Antibody Development Services Introduction
        11.5.4 Bio-Rad Revenue in Antibody Development Services Business (2017-2022)
        11.5.5 Bio-Rad Recent Development
    11.6 BioGenes
        11.6.1 BioGenes Company Detail
        11.6.2 BioGenes Business Overview
        11.6.3 BioGenes Antibody Development Services Introduction
        11.6.4 BioGenes Revenue in Antibody Development Services Business (2017-2022)
        11.6.5 BioGenes Recent Development
    11.7 ProteoGenix
        11.7.1 ProteoGenix Company Detail
        11.7.2 ProteoGenix Business Overview
        11.7.3 ProteoGenix Antibody Development Services Introduction
        11.7.4 ProteoGenix Revenue in Antibody Development Services Business (2017-2022)
        11.7.5 ProteoGenix Recent Development
    11.8 Labcorp
        11.8.1 Labcorp Company Detail
        11.8.2 Labcorp Business Overview
        11.8.3 Labcorp Antibody Development Services Introduction
        11.8.4 Labcorp Revenue in Antibody Development Services Business (2017-2022)
        11.8.5 Labcorp Recent Development
    11.9 Inotiv, Inc.
        11.9.1 Inotiv, Inc. Company Detail
        11.9.2 Inotiv, Inc. Business Overview
        11.9.3 Inotiv, Inc. Antibody Development Services Introduction
        11.9.4 Inotiv, Inc. Revenue in Antibody Development Services Business (2017-2022)
        11.9.5 Inotiv, Inc. Recent Development
    11.10 ProMab Biotechnologies
        11.10.1 ProMab Biotechnologies Company Detail
        11.10.2 ProMab Biotechnologies Business Overview
        11.10.3 ProMab Biotechnologies Antibody Development Services Introduction
        11.10.4 ProMab Biotechnologies Revenue in Antibody Development Services Business (2017-2022)
        11.10.5 ProMab Biotechnologies Recent Development
    11.11 Kemp Proteins
        11.11.1 Kemp Proteins Company Detail
        11.11.2 Kemp Proteins Business Overview
        11.11.3 Kemp Proteins Antibody Development Services Introduction
        11.11.4 Kemp Proteins Revenue in Antibody Development Services Business (2017-2022)
        11.11.5 Kemp Proteins Recent Development
    11.12 Synaptic Systems
        11.12.1 Synaptic Systems Company Detail
        11.12.2 Synaptic Systems Business Overview
        11.12.3 Synaptic Systems Antibody Development Services Introduction
        11.12.4 Synaptic Systems Revenue in Antibody Development Services Business (2017-2022)
        11.12.5 Synaptic Systems Recent Development
    11.13 ARVYS Proteins, Inc.
        11.13.1 ARVYS Proteins, Inc. Company Detail
        11.13.2 ARVYS Proteins, Inc. Business Overview
        11.13.3 ARVYS Proteins, Inc. Antibody Development Services Introduction
        11.13.4 ARVYS Proteins, Inc. Revenue in Antibody Development Services Business (2017-2022)
        11.13.5 ARVYS Proteins, Inc. Recent Development
    11.14 BBI Solutions
        11.14.1 BBI Solutions Company Detail
        11.14.2 BBI Solutions Business Overview
        11.14.3 BBI Solutions Antibody Development Services Introduction
        11.14.4 BBI Solutions Revenue in Antibody Development Services Business (2017-2022)
        11.14.5 BBI Solutions Recent Development
    11.15 Innovagen AB
        11.15.1 Innovagen AB Company Detail
        11.15.2 Innovagen AB Business Overview
        11.15.3 Innovagen AB Antibody Development Services Introduction
        11.15.4 Innovagen AB Revenue in Antibody Development Services Business (2017-2022)
        11.15.5 Innovagen AB Recent Development
    11.16 BIOTEM
        11.16.1 BIOTEM Company Detail
        11.16.2 BIOTEM Business Overview
        11.16.3 BIOTEM Antibody Development Services Introduction
        11.16.4 BIOTEM Revenue in Antibody Development Services Business (2017-2022)
        11.16.5 BIOTEM Recent Development
    11.17 Medimab
        11.17.1 Medimab Company Detail
        11.17.2 Medimab Business Overview
        11.17.3 Medimab Antibody Development Services Introduction
        11.17.4 Medimab Revenue in Antibody Development Services Business (2017-2022)
        11.17.5 Medimab Recent Development
    11.18 OriGene
        11.18.1 OriGene Company Detail
        11.18.2 OriGene Business Overview
        11.18.3 OriGene Antibody Development Services Introduction
        11.18.4 OriGene Revenue in Antibody Development Services Business (2017-2022)
        11.18.5 OriGene Recent Development
    11.19 Abeomics Inc.
        11.19.1 Abeomics Inc. Company Detail
        11.19.2 Abeomics Inc. Business Overview
        11.19.3 Abeomics Inc. Antibody Development Services Introduction
        11.19.4 Abeomics Inc. Revenue in Antibody Development Services Business (2017-2022)
        11.19.5 Abeomics Inc. Recent Development
    11.20 RayBiotech
        11.20.1 RayBiotech Company Detail
        11.20.2 RayBiotech Business Overview
        11.20.3 RayBiotech Antibody Development Services Introduction
        11.20.4 RayBiotech Revenue in Antibody Development Services Business (2017-2022)
        11.20.5 RayBiotech Recent Development
    11.21 Genscript Biotech Corporation
        11.21.1 Genscript Biotech Corporation Company Detail
        11.21.2 Genscript Biotech Corporation Business Overview
        11.21.3 Genscript Biotech Corporation Antibody Development Services Introduction
        11.21.4 Genscript Biotech Corporation Revenue in Antibody Development Services Business (2017-2022)
        11.21.5 Genscript Biotech Corporation Recent Development
    11.22 Sino Biological
        11.22.1 Sino Biological Company Detail
        11.22.2 Sino Biological Business Overview
        11.22.3 Sino Biological Antibody Development Services Introduction
        11.22.4 Sino Biological Revenue in Antibody Development Services Business (2017-2022)
        11.22.5 Sino Biological Recent Development
    11.23 Abzena Ltd
        11.23.1 Abzena Ltd Company Detail
        11.23.2 Abzena Ltd Business Overview
        11.23.3 Abzena Ltd Antibody Development Services Introduction
        11.23.4 Abzena Ltd Revenue in Antibody Development Services Business (2017-2022)
        11.23.5 Abzena Ltd Recent Development
    11.24 Creative Biolabs
        11.24.1 Creative Biolabs Company Detail
        11.24.2 Creative Biolabs Business Overview
        11.24.3 Creative Biolabs Antibody Development Services Introduction
        11.24.4 Creative Biolabs Revenue in Antibody Development Services Business (2017-2022)
        11.24.5 Creative Biolabs Recent Development
    11.25 Abcam
        11.25.1 Abcam Company Detail
        11.25.2 Abcam Business Overview
        11.25.3 Abcam Antibody Development Services Introduction
        11.25.4 Abcam Revenue in Antibody Development Services Business (2017-2022)
        11.25.5 Abcam Recent Development
    11.26 Antibodies Incorporated
        11.26.1 Antibodies Incorporated Company Detail
        11.26.2 Antibodies Incorporated Business Overview
        11.26.3 Antibodies Incorporated Antibody Development Services Introduction
        11.26.4 Antibodies Incorporated Revenue in Antibody Development Services Business (2017-2022)
        11.26.5 Antibodies Incorporated Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Antibody Development Services Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibody Development
    Table 3. Key Players of Polyclonal Antibody Development
    Table 4. Global Antibody Development Services Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Antibody Development Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Antibody Development Services Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Antibody Development Services Market Share by Region (2017-2022)
    Table 8. Global Antibody Development Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Antibody Development Services Market Share by Region (2023-2028)
    Table 10. Antibody Development Services Market Trends
    Table 11. Antibody Development Services Market Drivers
    Table 12. Antibody Development Services Market Challenges
    Table 13. Antibody Development Services Market Restraints
    Table 14. Global Antibody Development Services Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Antibody Development Services Market Share by Players (2017-2022)
    Table 16. Global Top Antibody Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Development Services as of 2021)
    Table 17. Ranking of Global Top Antibody Development Services Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Antibody Development Services Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Antibody Development Services Product Solution and Service
    Table 21. Date of Enter into Antibody Development Services Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Antibody Development Services Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Antibody Development Services Revenue Market Share by Type (2017-2022)
    Table 25. Global Antibody Development Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Antibody Development Services Revenue Market Share by Type (2023-2028)
    Table 27. Global Antibody Development Services Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Antibody Development Services Revenue Market Share by Application (2017-2022)
    Table 29. Global Antibody Development Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Antibody Development Services Revenue Market Share by Application (2023-2028)
    Table 31. North America Antibody Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Antibody Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Antibody Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Antibody Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Antibody Development Services Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Antibody Development Services Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Antibody Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Antibody Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Antibody Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Antibody Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Thermo Fisher Scientific Company Detail
    Table 42. Thermo Fisher Scientific Business Overview
    Table 43. Thermo Fisher Scientific Antibody Development Services Product
    Table 44. Thermo Fisher Scientific Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 45. Thermo Fisher Scientific Recent Development
    Table 46. R&D Systems Company Detail
    Table 47. R&D Systems Business Overview
    Table 48. R&D Systems Antibody Development Services Product
    Table 49. R&D Systems Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 50. R&D Systems Recent Development
    Table 51. Leinco Technologies Company Detail
    Table 52. Leinco Technologies Business Overview
    Table 53. Leinco Technologies Antibody Development Services Product
    Table 54. Leinco Technologies Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 55. Leinco Technologies Recent Development
    Table 56. Rockland Immunochemicals, Inc. (Rockland) Company Detail
    Table 57. Rockland Immunochemicals, Inc. (Rockland) Business Overview
    Table 58. Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Product
    Table 59. Rockland Immunochemicals, Inc. (Rockland) Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 60. Rockland Immunochemicals, Inc. (Rockland) Recent Development
    Table 61. Bio-Rad Company Detail
    Table 62. Bio-Rad Business Overview
    Table 63. Bio-Rad Antibody Development Services Product
    Table 64. Bio-Rad Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 65. Bio-Rad Recent Development
    Table 66. BioGenes Company Detail
    Table 67. BioGenes Business Overview
    Table 68. BioGenes Antibody Development Services Product
    Table 69. BioGenes Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 70. BioGenes Recent Development
    Table 71. ProteoGenix Company Detail
    Table 72. ProteoGenix Business Overview
    Table 73. ProteoGenix Antibody Development Services Product
    Table 74. ProteoGenix Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 75. ProteoGenix Recent Development
    Table 76. Labcorp Company Detail
    Table 77. Labcorp Business Overview
    Table 78. Labcorp Antibody Development Services Product
    Table 79. Labcorp Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 80. Labcorp Recent Development
    Table 81. Inotiv, Inc. Company Detail
    Table 82. Inotiv, Inc. Business Overview
    Table 83. Inotiv, Inc. Antibody Development Services Product
    Table 84. Inotiv, Inc. Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 85. Inotiv, Inc. Recent Development
    Table 86. ProMab Biotechnologies Company Detail
    Table 87. ProMab Biotechnologies Business Overview
    Table 88. ProMab Biotechnologies Antibody Development Services Product
    Table 89. ProMab Biotechnologies Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 90. ProMab Biotechnologies Recent Development
    Table 91. Kemp Proteins Company Detail
    Table 92. Kemp Proteins Business Overview
    Table 93. Kemp Proteins Antibody Development ServicesProduct
    Table 94. Kemp Proteins Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 95. Kemp Proteins Recent Development
    Table 96. Synaptic Systems Company Detail
    Table 97. Synaptic Systems Business Overview
    Table 98. Synaptic Systems Antibody Development ServicesProduct
    Table 99. Synaptic Systems Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 100. Synaptic Systems Recent Development
    Table 101. ARVYS Proteins, Inc. Company Detail
    Table 102. ARVYS Proteins, Inc. Business Overview
    Table 103. ARVYS Proteins, Inc. Antibody Development ServicesProduct
    Table 104. ARVYS Proteins, Inc. Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 105. ARVYS Proteins, Inc. Recent Development
    Table 106. BBI Solutions Company Detail
    Table 107. BBI Solutions Business Overview
    Table 108. BBI Solutions Antibody Development ServicesProduct
    Table 109. BBI Solutions Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 110. BBI Solutions Recent Development
    Table 111. Innovagen AB Company Detail
    Table 112. Innovagen AB Business Overview
    Table 113. Innovagen AB Antibody Development ServicesProduct
    Table 114. Innovagen AB Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 115. Innovagen AB Recent Development
    Table 116. BIOTEM Company Detail
    Table 117. BIOTEM Business Overview
    Table 118. BIOTEM Antibody Development ServicesProduct
    Table 119. BIOTEM Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 120. BIOTEM Recent Development
    Table 121. Medimab Company Detail
    Table 122. Medimab Business Overview
    Table 123. Medimab Antibody Development ServicesProduct
    Table 124. Medimab Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 125. Medimab Recent Development
    Table 126. OriGene Company Detail
    Table 127. OriGene Business Overview
    Table 128. OriGene Antibody Development ServicesProduct
    Table 129. OriGene Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 130. OriGene Recent Development
    Table 131. Abeomics Inc. Company Detail
    Table 132. Abeomics Inc. Business Overview
    Table 133. Abeomics Inc. Antibody Development ServicesProduct
    Table 134. Abeomics Inc. Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 135. Abeomics Inc. Recent Development
    Table 136. RayBiotech Company Detail
    Table 137. RayBiotech Business Overview
    Table 138. RayBiotech Antibody Development ServicesProduct
    Table 139. RayBiotech Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 140. RayBiotech Recent Development
    Table 141. Genscript Biotech Corporation Company Detail
    Table 142. Genscript Biotech Corporation Business Overview
    Table 143. Genscript Biotech Corporation Antibody Development ServicesProduct
    Table 144. Genscript Biotech Corporation Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 145. Genscript Biotech Corporation Recent Development
    Table 146. Sino Biological Company Detail
    Table 147. Sino Biological Business Overview
    Table 148. Sino Biological Antibody Development ServicesProduct
    Table 149. Sino Biological Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 150. Sino Biological Recent Development
    Table 151. Abzena Ltd Company Detail
    Table 152. Abzena Ltd Business Overview
    Table 153. Abzena Ltd Antibody Development ServicesProduct
    Table 154. Abzena Ltd Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 155. Abzena Ltd Recent Development
    Table 156. Creative Biolabs Company Detail
    Table 157. Creative Biolabs Business Overview
    Table 158. Creative Biolabs Antibody Development ServicesProduct
    Table 159. Creative Biolabs Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 160. Creative Biolabs Recent Development
    Table 161. Abcam Company Detail
    Table 162. Abcam Business Overview
    Table 163. Abcam Antibody Development ServicesProduct
    Table 164. Abcam Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 165. Abcam Recent Development
    Table 166. Antibodies Incorporated Company Detail
    Table 167. Antibodies Incorporated Business Overview
    Table 168. Antibodies Incorporated Antibody Development ServicesProduct
    Table 169. Antibodies Incorporated Revenue in Antibody Development Services Business (2017-2022) & (US$ Million)
    Table 170. Antibodies Incorporated Recent Development
    Table 171. Research Programs/Design for This Report
    Table 172. Key Data Information from Secondary Sources
    Table 173. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antibody Development Services Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibody Development Features
    Figure 3. Polyclonal Antibody Development Features
    Figure 4. Global Antibody Development Services Market Share by Application in 2021 & 2028
    Figure 5. Medical Industry Case Studies
    Figure 6. Biological Industry Case Studies
    Figure 7. Others Case Studies
    Figure 8. Antibody Development Services Report Years Considered
    Figure 9. Global Antibody Development Services Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Antibody Development Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Antibody Development Services Market Share by Region: 2021 VS 2028
    Figure 12. Global Antibody Development Services Market Share by Players in 2021
    Figure 13. Global Top Antibody Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Development Services as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Antibody Development Services Revenue in 2021
    Figure 15. North America Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Antibody Development Services Market Share by Country (2017-2028)
    Figure 17. United States Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Antibody Development Services Market Share by Country (2017-2028)
    Figure 21. Germany Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Antibody Development Services Market Share by Region (2017-2028)
    Figure 29. China Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Antibody Development Services Market Share by Country (2017-2028)
    Figure 37. Mexico Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Antibody Development Services Market Share by Country (2017-2028)
    Figure 41. Turkey Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Antibody Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Thermo Fisher Scientific Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 44. R&D Systems Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 45. Leinco Technologies Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 46. Rockland Immunochemicals, Inc. (Rockland) Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 47. Bio-Rad Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 48. BioGenes Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 49. ProteoGenix Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 50. Labcorp Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 51. Inotiv, Inc. Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 52. ProMab Biotechnologies Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 53. Kemp Proteins Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 54. Synaptic Systems Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 55. ARVYS Proteins, Inc. Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 56. BBI Solutions Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 57. Innovagen AB Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 58. BIOTEM Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 59. Medimab Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 60. OriGene Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 61. Abeomics Inc. Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 62. RayBiotech Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 63. Genscript Biotech Corporation Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 64. Sino Biological Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 65. Abzena Ltd Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 66. Creative Biolabs Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 67. Abcam Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 68. Antibodies Incorporated Revenue Growth Rate in Antibody Development Services Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific
R&D Systems
Leinco Technologies
Rockland Immunochemicals, Inc. (Rockland)
Bio-Rad
BioGenes
ProteoGenix
Labcorp
Inotiv, Inc.
ProMab Biotechnologies
Kemp Proteins
Synaptic Systems
ARVYS Proteins, Inc.
BBI Solutions
Innovagen AB
BIOTEM
Medimab
OriGene
Abeomics Inc.
RayBiotech
Genscript Biotech Corporation
Sino Biological
Abzena Ltd
Creative Biolabs
Abcam
Antibodies Incorporated
Frequently Asked Questions
Antibody Development Services report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antibody Development Services report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antibody Development Services report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports